The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2023 | PREDICT-MESO: a mesothelioma investigatory network
Kevin Blyth, MBChB, MD, FRCP, University of Glasgow, Glasgow, UK, outlines the goals of PREDICT-MESO, an international accelerated network which aims to understand the evolution of benign pleural inflammation into mesothelioma. By understanding this method, they are striving to develop treatments, particularly for early-stage disease, or even preventative therapies for high-risk cases. This interview took place at the British Thoracic Oncology Group (BTOG) Annual Conference 2023 in Belfast, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
